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Abstract
Breast cancer is among the most common type of cancer in women around 
the globe. Prevention of breast cancer is better than its treatment. Because of 
the molecular variation and complexity underlying breast cancer occurrence, its 
treatment by using chemotherapy and/or radiotherapy is very complicated and 
often leads to undesirable side effects. Plants and their extracts have been used 
for centuries for the treatment of almost every disease and breast cancer is not an 
exception. Herbal products can be trusted for cancer treatment because of their 
low toxicity. Besides, herbal remedies are easily accepted by the majority of woman 
suffering from breast cancer because of their easy availability and affordability. 
In the last decade, a large number of plants and their compounds were reported to 
show promising anticancerous effects against breast cancer cells in both in vivo and 
in vitro models. However, their beneficial effects on breast cancer treatment are still 
doubtful due to the lack of randomized clinical trials. This chapter is dedicated to 
reporting the potential of some herbal products for the prevention and/or treatment 
of breast cancer. Besides, it focused on the anticarcinogenic mechanism of those 
phytocompounds to report their potential chemotherapeutic role.
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1. Introduction
According to World Health Organization (WHO), cancer is the second leading 
cause of death after cardiovascular diseases and a growing health issue globally. 
Breast cancer is the most commonly diagnosed type of cancer among females 
accounting for approximately one-quarter of cancers in females globally. Great 
research efforts are in place to understand the cause of breast cancer onset, to iden-
tify the critical molecular mechanism of its progression, and to define new ways of 
treating it with lower and limited toxicity. These efforts are certainly encouraging 
since overall survival has greatly improved in several breast cancer types during the 
last decade. Since 1990, mortality rates of breast cancer have reduced significantly 
by 25%, this is at least in part due to the significant improvement in its treatment 
[1]. Treatment of cancer mainly relies on chemotherapy that uses cytotoxic agents 
for killing cancer cells. However, these agents or drugs affect both cancer cells as 
well as healthy cells, causing an array of side effects during the therapy or after the 
therapy. To overcome these problems, current research is emphasized to explore 
herbal remedies that selectively targets cancer cells. Besides this, unlike other 
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cancer types, breast cancer has diverse genetic mutations that affect several path-
ways [2]. These complexities aid to distinct pathological types with different clinical 
outcomes [3]. Therefore, response to a certain chemotherapeutic drug may differ 
in different patients and lack of proper treatment plan may increase the toxicity 
furthermore. One of the encouraging approaches to overcome drug toxicity is to 
look for alternative medicines that have less or selective toxicity toward cancer cells 
[4]. In recent years, many studies have demonstrated selective cytotoxicity of a 
variety of herbal compounds that can be used as potential chemotherapeutics [4]. 
Meanwhile, diverse herbal products were reported to prevent and/or palliate the 
side effects of treatment, improve quality of life, and reduce stress. However, the 
usefulness of herbal remedies for breast cancer prevention and/or treatment is still 
ambiguous due to the lack of randomized clinical trials. These objectives will be 
achievable only if the herbal compounds that showed promising anticancer activity 
can be successfully transferred to clinical trials.
2. Current scenario and future burden of breast cancer
Cancer of the breast is among the most frequently diagnosed cancer and 
the leading cause of cancer-related deaths in females globally. According to 
International Agency for Research on Cancer (IARC’s) Globocan data on 2018, 
breast cancer caused 0.62 million deaths in 2018 and another 2.08 million new cases 
were identified, which is 11.6% of all cancer types recorded [5]. At the current rate, 
the number of incident cases is expected to rise to 3.05 million, and the mortality 
troll is expected to rise to a nerve-racking 6.99 million by 2040 [6]. Approximately 
1 in 10 women is diagnosed with breast cancer at some time in their lives [3].
Epidemiological observation shows that the incidence of breast cancer is contin-
uously raising in both industrialized and developing countries [7]. Breast cancer is a 
disease largely triggered by environmental and lifestyle factors than genetic, which 
is believed to be responsible for only 10–15% of all breast cancer cases [8]. Various 
risk factors like age (>50), family history of breast cancer, woman’s reproductive 
history such as early menarche, nulliparity or late pregnancy, and late menopause 
mainly aid to breast cancer onset [9]. In addition, prolonged use of oral contracep-
tive and hormone replacement therapy are also known risk factors of this disease 
among postmenopausal women [10].
3.  Molecular feature of breast cancer occurrence, progression,  
and treatment
The onset of cancer is a result of several sequential molecular events. Most com-
mon of them is a mutation in a DNA molecule that codes for a protein that either 
triggers cell division, proliferation, and growth or that signals termination of all 
these molecular events [11]. Therefore, damage to DNA or a protein that regulates 
cell cycle may lead to uncontrolled division and growth of cells, the condition is 
cancer. It is a hyperproliferative disease that involves molecular alteration resulting 
in apoptosis dysregulation, proliferation, angiogenesis, and metastasis [12].
Breast cancer is one of the commonest types of cancer and characterized by 
distinct pathological types with different clinical outcomes. It has different stages 
that arise from ductal hyperproliferation, which changes into ductal carcinoma in 
situ (DCIS), invasive carcinoma, and metastatic stage. In addition, based on the 
molecular mechanism of occurrence, breast cancer can be divided into estrogen 
receptor (ERα) and progesterone receptor (PR) expression and amplification 
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of human epidermal growth factor receptor (HER2), also known as epidermal 
growth factor receptor 2 (ErbB2) [3]. Breast cancer 1 (BRCA1) and breast cancer 
2 (BRCA2) are the two most important genes that code the proteins BRCA-1 and 
BRCA-2, which play a key role in DNA damage repair and in maintaining genomic 
stability [3]. Mutation in these genes leads to 15–20 fold increases the risk of breast 
cancer occurrence [13]. Additionally, tumor suppressor TP53 is another important 
gene that codes for the protein p53 that plays a major role in the regulation of cell 
cycle and in apoptosis induction. Mutation in the TP53 gene increases the risk of 
breast cancer as well as other cancer types. Breast cancer cell survival, prolifera-
tion, motility, and cell metabolism are controlled by various signaling cascades. 
In around 70% of breast cancers, the phosphatidylinositol 3-kinase (PI3K)/
AKT pathway has shown to be mutated [14]. Other frequently mutated signaling 
cascades in breast cancer are Janus kinase (JAK)/signal transducer, activators of 
transcription (STAT), and nuclear factor κβ (NF-κβ) pathways [3]. Classification 
of breast cancer based on the molecular expression has therapeutic implication as it 
helps in deciding the treatment plan. Based on the relative expression of the above 
markers, patients either receives hormonal therapy or chemo/targeted therapies. 
The most promising way of dealing with cancer is to interfere with modulation 
stages of carcinogenesis—initiation, promotion, and progression as well as altering 
the carcinogenesis signaling pathways [15, 16].
Breast cancer therapeutics include drugs that protect genomic stability by 
preventing DNA damage, inhibit the cell cycle by disrupting cellular integrity or 
by inducing apoptotic cell death, and block certain pathways that are responsible 
for abnormal cell growth (Table 1). Majority of breast cancer cases express the 
estrogen hormone receptor, which helps the cancer cells to proliferate rapidly by 
the growth-promoting effects of circulatory estrogens [17]. Therefore, current 
therapies are targeted at abrogating estrogen dependence for estrogen receptor 
(ER)-positive breast cancers [17]. One of the successful and efficient approaches is 
the employment of a selective estrogen receptor modulator (SERM) like tamoxifen, 
which binds to the ER that induces a conformational change in the receptor result-
ing in obstruction of estrogenic expression [18, 19]. However, tamoxifen like SERMs 
exhibits many notable side effects including—secondary cancer, cardiovascular 
diseases by their estrogenic activity in other tissues and organs. The efficiency of 
tamoxifen is challenged by the development of highly potent third-generation aro-
matase inhibitors (AIs) that represents a promising approach in endocrine therapy 
of breast cancer [20]. The aromatase inhibitor drugs like anastrozole and letrozole 
reduce estrogen production by competitive inhibition of the enzyme aromatase, 
although the long-term health effects of AIs are doubtful [21]. Another effective 
strategy in breast cancer treatment is the implementation of a growth factor inhibi-
tor. One of the first identified targets of these growth inhibitors was the epidermal 
growth factor receptor (EGFR) that plays a vital role in the survival of cancer cells 
and developing multidrug resistance [22]. The effectiveness of the small molecule 
EGFR tyrosine kinase inhibitor like gefitinib is highly appreciated for the treatment 
of breast cancer; however, it failed to produce notable improvement in advance 
stages of breast cancer [23].
Approximately 20% of breast cancer cases show overexpression of the HER2 
that results in aggressive disease and reduced survival [17]. In present, trastuzumab 
and lapatinib are the only marketed drugs used to inhibit the HER2-mediated 
growth and proliferation signaling [17]. Other than this, enzyme-mediated DNA 
damage is an effective approach used in cancer chemotherapy. Doxorubicin, an 
anthracycline drug, binds with DNA by intercalation with base pairs, which results 
in an elevated level of DNA-topoisomerase II covalent complexes inhibiting topoi-
somerase II activity [24]. Other anticancer drugs inhibit mitosis by interrupting the 
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microtubule stability, hence blocking the transition from metaphase to anaphase 
[25]. Subsequently, the cell undergoes mitotic arrest or programmed cell death 
(apoptosis). For instance, vincristine and vinorelbine inhibit the polymerization of 
microtubules by binding to either the vinca domain or taxoid-binding domain that 
interferes between β- and α-subunit of tubulin [25]. On the other hand, microtubule-
stabilizing drugs like paclitaxel hyperstabilizes the microtubule assembly by binding 
to the inner surface of the microtubule at a taxoid-binding site on β-tubulin resulting 
in mitotic arrest in the cell [25]. All these strategies helped in reducing mortality due 
to breast cancer and increased the survival rate; however, they appear with certain 
side effects that may be either low and short term or high and life threatening.
4. Chemotherapeutic-associated toxicity in breast cancer treatment
The role of chemotherapy in curing cancer is still doubtful [27]. Even it 
decreases the risk of recurrence and helps the patient to live longer with improved 
quality of life in case of metastatic breast cancer. But its use associated with 
certain risk factors or side effects—some of the side effects are short term and 
minor, whereas others may become more serious and life threatening [27]. Table 2 
describes a few commonly used chemotherapeutic drugs and their side effects.
Among the most common side effects of chemotherapeutic drugs is its nonselec-
tive toxicity, where it destroys the normal body cells such as those in the hair follicle, 
Table 1. 
Commonly used breast cancer chemotherapeutic drugs, their targets, and mechanism of action [26].
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bone marrow, and cells of other important organs along with the cancer cells. Quite 
a few chemotherapeutic drugs affect the nerve endings or synaptic gaps in hands 
and feet that may result into numbness, pain, burning or tingling, sensitivity to cold 
or heat, or weakness in your extremities [31]. Besides, chemotherapeutic drugs may 
severely damage the immune cells as wells as the brain cells, making the patient 
vulnerable to infectious diseases and impaired cognitive functions [32]. These side 
effects may be temporary and may disappear after a few months of completion of 
chemotherapy. Other critical side effects that arise due to certain chemotherapeutic 
drugs may last longer—infertility is one of them [33]. Chemotherapeutics that dam-
age ovaries may lead to menopause symptoms, like hot flashes and vaginal dryness, 
where menstrual cycle becomes irregular or permanently ceases making pregnancy 
impossible [34]. Further, early menopause in premenopausal women due to the use 
of aromatase inhibitor agents in adjuvant therapy causes a hypoestrogenic condition 
that negatively impacts bone density resulting in osteopenia or osteoporosis [35].
Besides, long-term chemotherapeutic toxicity results in cardiac diseases and 
may trigger secondary cancer such as marrow neoplasm or leukemia [36, 37]. 
Chemotherapy-linked cardiotoxicity is another major setback of cancer therapy 
that increases the mortality rate because of the high prevalence of cardiovascular 
diseases in cancer patients [38]. The cardiotoxicity leads to congestive heart failure 
(CHF), which is more prevalence in young and elderly patients. It has been reported 
Table 2. 
Frequently used chemotherapeutic drugs in breast cancer treatment and their common side effects associated 
with them [26, 28–30].
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that the breast cancer patients aged between 65 and 70 years, who received adjuvant 
anthracycline chemotherapy, had significantly higher rates of CHF [39]. In another 
investigation, a widely used chemotherapeutic drug, doxorubicin, was reported 
to cause CHF in worryingly 26% of the patients suffering from breast carcinoma 
[40, 41]. Additionally, it was observed that 0.5% of breast cancer patients devel-
oped different types of marrow neoplasm (MN) or leukemia after a few years of 
chemotherapy [42]. The risk of developing MN is higher in the first few years after 
chemotherapy. Furthermore, chemotherapeutic drugs may also disrupt the normal 
psychological state of patients in certain cases [43, 44].
The side effects that arise due the conventional chemotherapy is mainly due 
to lack of specificity of the drugs for cancer cells. Majority of the widely used 
chemotherapeutic drugs causes adverse damage to normal cells and key organs, 
which limits the dose of a drug that can be used [45]. This explains the reason 
why cancer drugs have a low therapeutic index. Several approaches are being 
considered to address this issue in order to improve the effectiveness of antican-
cer drugs. One of the popular approaches among them is searching for natural 
compounds that inhibit cancer cell growth without disrupting the functioning of 
healthy cells.
5. Ethnomedicine and herbal compounds used for cancer treatment
Plants have played a key role in the survival and evolution of human beings 
as they have provided the basic need of mankind like food, clothing, shelter, and 
medicine since the beginning of the human race. Plants have formed the basis 
of traditional medicine systems like Ayurveda, Unani, and Chinese traditional 
medicines that have served mankind with their health needs. A larger part of the 
population in developing and underdeveloped countries relies on herbal medicine 
for solving treating their primary health issues. Traditional herbal medicines 
become popular because of their cost-effectiveness, abundancy, and less or no side 
effects. In recent years, global emphasis on plant research has increased to find out 
drug-like substances from traditionally used medicinal plants. Moreover, several 
naturally occurring plant-based compounds like curcumin, resveratrol, quercetin, 
and many more showed promising anticancerous effects and are gaining interest 
as an adjuvant chemotherapeutic agent. Besides, naturally occurring compounds 
cause less toxicity to healthy cells and in certain cases show selective toxicity against 
abnormal or diseased cells [46]. This might be the reason that today a large number 
of drugs being marketed are structurally similar to the structure of naturally occur-
ring compounds.
Herbal compounds show a variety of anticancer activity mainly antioxidant, 
anti-inflammatory, antimutagenic, and apoptosis-inducing activity that may 
help prevent cancer development in the early stage (Figure 1). Dietary consump-
tion of adequate quantity of these herbal products may help in prevention and 
treatment of breast cancer by cell cycle arrest, induction of apoptosis, regulat-
ing carcinogen metabolism and oncogenic expression, inhibiting cell adhesion, 
proliferation and migration, and blocking signaling pathways that are essential 
for cancer progression [47].
Between the year 1981 and 2014, 136 anticancer drugs were brought to use 
around the globe, almost 83% of which were either herbal compounds or their 
derivatives [48]. A number of anticancer drugs have already in use for the treatment 
of breast cancer—including vincristine, vinblastine, paclitaxel, and docetaxel [49]. 
Despite the success of herbal products in curing breast cancer and its associated 
complexities, not many herbal products are making through preclinical or clinical 
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trials. Hence, greater effort is necessary to successfully transfer these agents to an 
ideal clinical setting to assess their potential for herbal therapies.
Figure 1. 
Features of herbal compounds that attribute to their anticancer activity.
Figure 2. 
Some important members of different classes of phytoestrogens [61].
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6. Herbal products used for prevention of breast cancer
Breast cancer is a preventable disease [50]. Estrogens play a major role in promot-
ing the proliferation of normal breast cells as well as neoplastic breast epithelium [51]. 
Almost 40–70% of breast cancers are estrogen receptor positive [52]. Hence, blocking 
the estrogen receptor for the treatment and chemoprevention of breast cancer is one 
of the significant approaches. Plant-based estrogen-like compounds or phytoestro-
gens were originally proposed as cancer-protective agents. This claim was strongly 
supported by an epidemiological study that revealed a low breast cancer incidence 
in the soy-consuming population [53, 54]. Phytoestrogens are structural analogues 
of the mammalian hormone, estrogen, and thus can bind weakly to the hormone 
receptor [55]. Structurally, phytoestrogen can be grouped into flavones, flavanones, 
lignans, coumestans, and stilbenes [56]. The structure of important members of 
different classes of phytoestrogens is given in Figure 2. Soybean and soy product is a 
rich source of isoflavones [57]. Other phytoestrogen classes are legumes and lignans 
found in seeds, nuts, whole grains, fruit, and vegetables [57]. Historically, the rate of 
breast cancer occurrence in the United States is 4–7 times higher than that of Asian 
population where the consumption of dietary isoflavones is comparatively as higher 
as 20 to 80 mg/d [58]. In addition, epidemiological observations also revealed a mod-
est 30% reduction in breast cancer risk for women with a higher percentage of dietary 
lignan intake [57]. Therefore, consumption of phytoestrogen-rich diet is one of the 
many potential protective lifestyles against breast cancer. Recently, there are increas-
ing pieces of evidence that phytoestrogen activity inhibits key steroidogenic enzymes 
activity involved in the synthesis of estradiol from circulating androgens and estrogen 
sulfate [7]. Consequently, this activity could play a major role in protection against 
breast cancer. Besides inhibiting the estrogenic activity, phytoestrogens were also 
reported to activate the G-protein coupled receptor, GPR30 or GPER-1, described as a 
novel estrogen receptor and play a significant role in estrogen-dependent diseases like 
breast cancer [59]. However, the activity of phytoestrogens is unclear and depends on 
more than one factors that include—its structure, metabolism, its relative availability 
compared to that of endogenous estrogen [60, 57].
Naturally occurring phenolic compounds namely phenolic acids, flavonoids, 
tannins, quinones, anthocyanins, and others play an important role in cancer 
prevention and/or treatment [47]. These phenolic compounds are ubiquitous and 
rich in medicinal herbs and dietary plants. Several phenolic compounds contribute 
toward inhibiting carcinogenesis mechanism and show chemopreventive activities 
by their diverse range of biological activities [62] (Table 4).
7. Herbal products used for treatment of breast cancer
A recent population-based survey showed that almost 80% of the women suffer-
ing from breast cancer use some form of complementary or alternative medicine for 
the treatment of cancer [63]. Herbal remedies are the most common and popular 
form of alternative medicine among them, which is frequently used by women suf-
fering from breast cancer. Here is some evidence that can help to treat breast cancer 
and its associated toxicity:
7.1 Choosing a selectively cytotoxic herbal cure
One of the interesting features for herbal remedies is their selective toxicity 
toward cancer cells. There are a number of phytocompounds reported that have 
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selective toxicity toward breast cancer cells. Artemisinin is one among them, 
isolated from Artemisia annua L. proved to be selectively cytotoxic toward breast 
cancer cells when an adequate amount of iron (i.e., ferrous iron) is present in the 
cells. Because cancer cells have a higher iron influx, therefore, artemisinin and its 
analogues can selectively destroy cancer cells under high iron concentration [64]. 
Besides, polyphenols from Artemisia annua L. were reported to inhibit the adhesion 
and epithelial-mesenchymal transition (EMT) of highly metastatic breast cancer 
cells, MDA-MB-231 [65]. Other than this, polyphenol-rich extracts of Hibiscus 
sabdariffa and aqueous extract of Brucea javanica were also reported to show selec-
tive cytotoxicity toward MCF7 and HTB-126 breast cancer cell lines, respectively 
[66, 67]. However, further exploration is necessary to isolate the selective cytotoxic 
ingredients of these plants (Table 3).
7.2 Combination therapy by herbal remedies and synthetic drugs
Combination therapy of herbal therapy and synthetic drugs possibly be the last 
resource for patients in the final stage of breast cancer, where surgery is not possible 
[69]. The combinatory effect of a herbal drug with conventional cancer drugs might 
improve the bioavailability of one of them making the treatment more effective 
[69, 70]. Additionally, the combinatory use of herbal remedies with chemotherapy 
will reduce the dose of standard medicine resulting in lower toxicity and side 
effects [71]. Several researchers have suggested that herbal compounds can be used 
in a therapeutic modality as it enhances the anticancer activity of current drugs. 
Curcumin, a renowned anticancer herbal compound down-regulated the expres-
sion of breast cancer markers in vivo and in vitro when administered along with 
Table 3. 
Plant-based cancer therapeutics in different stages of clinical trials and research [68].
Medicinal Plants - Use in Prevention and Treatment of Diseases
10
chemotherapeutic drugs cyclophosphamide and paclitaxel that made the cancer 
cells more viable to the drugs [72, 73]. Similarly, 20S-protopanaxadiol, a metabolite 
of ginsenosides, inhibited cell proliferation in MCF-7 cells by interfering with 
estrogenic gene expression when used in combination with tamoxifen [74]. Besides, 
this combination asynergistically improved the cytotoxicity of tamoxifen in an 
ER-independent manner [74]. Hence, the benefits of these herbal compounds in 
synergistic therapy are considerable, and this might help to overcome chemothera-
peutic drug resistance and toxicity in breast cancer treatment.
7.3 Herbal supplements and nutraceuticals for breast cancer therapy
Cancer has been shown to be a preventable disease with changes in nutrition 
and dietary changes. A previous investigation showed that almost 35% of cancers 
are related to diet [75]. There are several confirmations from epidemiological and 
laboratory studies that sufficient intake of fruit, vegetables, and herbal supplements is 
inversely linked with breast cancer occurrence. A diet composed of adequate quantity 
of phytoestrogens, polyphenols, and rich sources of other chemopreventive agents 
helps in reducing breast cancer risk. Dietary supplements of the herbal source are less 
toxic and easily metabolized. Besides, dietary consumption of these herbal remedies 
helps in fighting side effects in postchemotherapy patients. One of the primary symp-
toms of adjuvant chemotherapeutic damage in posttherapy breast cancer patients is 
hot flushes. Black cohosh or Actaea racemosa plant is popularly used by patients of 
breast cancer to treat hot flushes, which gives conflicting but promising results [76].
8.  Molecular mechanism of anticancerous activity of herbal compounds 
on breast cancer
As discussed in the earlier section, herbal compounds show a verity of anti-
cancer actions—including antioxidant, cytotoxic, antiproliferative, apoptotic 
activity, etc. Plant-based cancer agents broadly classified into five groups that 
include—methyltranferase inhibitors, DNA protecting agents, antioxidants, histone 
deacetylases inhibitors, and mitosis disruptors. Generally, plant-derived com-
pounds contribute toward the anticarcinogenesis mechanism by their antioxidant, 
cytotoxic, antimitotic, and apoptotic activity (Table 4). Others help in chemo-
prevention by preventing DNA damage, modulating carcinogenesis signaling, and 
inducing apoptotic cell death (Table 4). Several in vitro and in vivo investigations 
support the activity of herbal compounds that linked with their anticancer activity. 
Here’s is a few examples of the anticancer mechanism of herbal compounds.
8.1 Antioxidant activity of herbal compounds
Antioxidant activity of herbal compounds of oxidative stress is developed when 
the balance between the production of reactive oxygen species (free radicals) and 
antioxidant defense is disturbed [77]. Oxidative stress development and consequent 
reactive oxygen species (ROS) generation are linked with several disease pathogen-
esis including cancer. Oxidative stress is dealt with by the body’s antioxidant mecha-
nism and several herbal compounds help boosting this machinery. For instance, 
curcumin enhances the activity of antioxidant enzymes resulting in enhanced 
cellular resistance to oxidative damage [78]. In addition, curcumin was also found 
to rise hepatic GSH, SOD, GPx, GR, GST, and CAT activities in paracetamol-treated 
rats [79]. Other plant-based compounds like epigallocatechin gallate, a component 
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Compound Structure Herbal source Activity References
Allyl 
isothiocyanate
Brassica nigra, 
Brassica juncea
Chemoprevention, 
detoxification, 
and reduces 
cancer risks. 
Inhibits mitosis 
and angiogenesis. 
Shows selective 
cytotoxicity.
[86, 87]
Artemisinin Artemisia annua Selective 
cytotoxicity, mitotic 
arrest, apoptosis, 
inhibition of 
angiogenesis, and 
ferroptosis.
[88, 89]
Biochanin A Trifolium 
pratense
Breast cancer 
preventive agent 
inhibits tumor 
growth.
[90, 91]
Bacosine Bacopa monnieri Anti-metastatic 
activity.
[92, 93]
Curcumin Curcuma longa Chemopreventive 
and antitumoral 
activities, 
anti-metastatic, 
apoptotic, modulate 
carcinogenesis 
signaling, help 
reducing drug 
toxicity.
[94–96]
Delphinidin 
3-sambubioside
Hibiscus 
sabdariffa
Antioxidant, 
cytotoxic, 
apoptotic, induces 
autophagy and 
necrosis.
[97, 98]
Epicatechin 
gallate
Parapiptadenia 
rigida, Hibiscus 
sabdariffa, 
component of 
green tea
Induces apoptosis 
and inhibits 
tumorigenesis, 
potential cancer 
chemopreventive 
agent.
[99–101]
Genistein Component of 
soy products
Chemoprevention, 
estrogenic activity, 
inhibition of 
tumorigenesis, 
inhibit 
topoisomerase 
II activity and 
angiogenesis
[102–104]
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of in green tea, found to reduce the levels of lipid peroxidation and protein carbonyl 
content in rats, possibly by enhancing the GSH redox status significantly when 
administered orally [80]. Likewise, several herbal compounds help to reduce oxida-
tive stress, hence play a preventive role against cancer onset.
8.2 Anti-angiogenesis activity of herbal compounds
Quite a few herbal compounds help to inhibit angiogenesis in breast cancer. 
Genistein, a flavonoid phytoestrogen, is the most potent angiogenesis inhibitor 
linked with reduced expression of VEGF, PDGF, uPA, and MMP-2 and MMP-9 [81]. 
Curcumin was even found to be an effective inhibitor of angiogenesis that reduces 
the expression of various proangiogenic proteins such as vascular endothelial growth 
factor (VEGF) and basic fibroblast growth factor [82]. Resveratrol and quercetin 
inhibited the migration and tube formation in bovine aorta endothelial cells conse-
quently inhibiting angiogenesis in those cells [83, 84]. In addition, catechin deriva-
tives, such as epicatechin (EC), epigallocatechin (EGC), epicatechin-3-gallate (ECG), 
and epigallocatechin-3-gallate (EGCG), present in green tea are potent angiogenesis 
inhibitors [85]. The anti-angiogenic activity of EGCG was demonstrated by inhibition 
of vascular endothelial growth factor (VEGF) production and reduction of matrix 
metalloproteinase-2 (MMP-2) activity in MDA-MB231 breast cancer cells [85].
Compound Structure Herbal source Activity References
Glycyrrhetinic 
acid
Glycyrrhiza 
glabra
Inhibition of cell 
proliferation, 
synergistic effect 
in combination 
with an anticancer 
drug, etoposide. 
Antineoplastic 
effect including 
apoptosis.
[105, 106]
Lycopene Component 
of tomatoes, 
pink grapefruit, 
apricots, red 
oranges.
Inhibition of cell 
cycle progression
[107, 108]
Protocatechuic 
acid
Dietary 
polyphenol 
found in many 
foods including 
Hibiscus 
sabdariffa, Ginkgo 
biloba, Hypericum 
perforatum
Apoptosis-
inducing agent, 
anti-metastatic.
[109–111]
Ursolic acid Many plants 
including Malus 
domestica, 
Origanum 
majorana
Antitumor, 
antioxidant, anti-
inflammatory, and 
anti-angiogenesis 
activity.
[112–114]
Table 4. 
Some novel compounds from herbal sources that showed promising anticancerous activity in both in vivo and 
in vitro studies.
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8.3 Apoptosis-inducing activity of herbal compounds
The apoptosis-inducing activity of herbal compounds is another favorable 
feature that contributes toward their anticancer effect. Curcumin was found to 
inhibit the proliferation and inducing apoptosis in several cancer cell lines including 
breast cancer cells such as T47D, MCF7, MDA-MB-231, and MDA-MB-468 [115]. 
Curcumin inhibited the phosphorylation of protein kinase B (Akt)/mammalian tar-
get of rapamycin (mTOR), decreased BCL2 expression, and elevated BAX expres-
sion and cleavage of caspase 3, subsequently inducing apoptosis of breast cancer 
cells [115]. Protocatechuic acid was also found to be a potent apoptosis inducer 
in five types of human cancer cell lines including breast, lung, liver, cervix, and 
prostate cancer cells [111], which was confirmed by DNA fragmentation, changes in 
mitochondrial membrane potential, and measurement of caspase activity. The fla-
vonoid 8-prenylnaringenin (8PN), a constituent of Humulus lupulus, is an effective 
phytocompound known for its growth-inhibiting and apoptotic activity in various 
human cancer types including breast cancer [116]. This activity of 8PN in MCF7 
breast cancer cells was possibly mediated by interference with an ER-associated 
PI3K pathway [116]. Other herbal compounds like lycopene inhibit cell cycle 
progression by reducing cyclin D expression and retention of p27 in cyclin E–cdk2, 
thus leading to inhibition of G1 CDK activities in human breast cell line MCF-7 and 
T-47D along with endometrial (ECC-1) cancer cells [108].
Interestingly, artemisinin, which is an ancient Chinese herbal compound for 
malarial fevers, has been recently found to have potent and selective toxicity against 
cancer cells. It reacts with iron to form free radicals with alkylating capacity that can 
kill cells. As cancer cells require a large quantity of iron uptake to proliferate, mak-
ing them more susceptible to the cytotoxic effect of artemisinin [117]. Besides, oral 
administration of artemisinin delayed the onset of breast cancer in 7, 12-dimethylbenz 
[a] anthracene (DMBA)-induced rats [118]. This encouraging results might lead to 
design novel chemotherapeutics with effective anticancer property and low toxicity.
9. Conclusion
Though, advances in healthcare research lead to the identification and charac-
terization of most breast cancer types and corresponding cure. However, incidence 
and prevalence of breast cancer is rising in terrifying rate in both developed and 
developing countries because of various risk factors. Improved synthetic drugs 
and hormonal therapy emerged in a decline in breast cancer incidences, increased 
survival, and better life quality. However, prolonged use of synthetic anticancer 
drugs is linked with several health risks or side effects that consequence from the 
toxic effect of these drugs in normal cells. Chemoprevention by herbal compounds 
is of great interest and is considered to be an inexpensive, readily applicable, 
acceptable, and accessible approach to cancer control and management. Herbal 
remedies play a significant role in the management of breast cancer and the associ-
ated therapeutic toxicity. The adjunct use of herbal products and chemotherapy can 
be an efficient and cost-effective way to treat breast cancer. Such adjuvant therapy 
proved to produce a synergistic anticancer effect that reduced the drug toxicity, 
suppresses drug resistance, and provides quick drug action enhancing the quality of 
treatment. Besides, combinatory therapy might also increase the therapeutic index 
of the synthetic partner by improving the efficiency of the drug. Plant-derived 
anticancer drugs such as vinblastine, vincristine, taxols, etc. showed encouraging 
chemotherapeutic potential that is currently used in breast cancer treatment and a 
large number of them are in preclinical or in clinical trials. In the last decade, a vast 
number of phytochemicals were identified that showed encouraging anticancer 
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activity in vivo and in vitro breast cancer models. Interestingly, several compounds 
like artemisinin and isothiocyanates showed selective toxicity toward cancer cells, 
which recommend clinical trials of these compounds. Furthermore, phytoestrogens 
with affinity and capacity to produce functional responses through estrogen recep-
tors revealed unique possibilities of using them in hormone replacement therapy. 
Overall, this chapter can conclude that understanding the molecular mechanism of 
interaction between herbal compounds and cancer cells in the tumoral environment 
can help us to design novel anticancer drugs that are less toxic and affordable. This 
reflects the fact that these goals will only be attainable if the herbal compounds that 
showed promising anticancer activity can be successfully transferred to an ideal 
clinical setting for the use of herbal therapies.
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